Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 4;10(2):e0116767.
doi: 10.1371/journal.pone.0116767. eCollection 2015.

Health care costs, utilization and patterns of care following Lyme disease

Affiliations

Health care costs, utilization and patterns of care following Lyme disease

Emily R Adrion et al. PLoS One. .

Abstract

Background: Lyme disease is the most frequently reported vector borne infection in the United States. The Centers for Disease Control have estimated that approximately 10% to 20% of individuals may experience Post-Treatment Lyme Disease Syndrome - a set of symptoms including fatigue, musculoskeletal pain, and neurocognitive complaints that persist after initial antibiotic treatment of Lyme disease. Little is known about the impact of Lyme disease or post-treatment Lyme disease symptoms (PTLDS) on health care costs and utilization in the United States.

Objectives: 1) to examine the impact of Lyme disease on health care costs and utilization, 2) to understand the relationship between Lyme disease and the probability of developing PTLDS, 3) to understand how PTLDS may impact health care costs and utilization.

Methods: This study utilizes retrospective data on medical claims and member enrollment for persons aged 0-64 years who were enrolled in commercial health insurance plans in the United States between 2006-2010. 52,795 individuals treated for Lyme disease were compared to 263,975 matched controls with no evidence of Lyme disease exposure.

Results: Lyme disease is associated with $2,968 higher total health care costs (95% CI: 2,807-3,128, p<.001) and 87% more outpatient visits (95% CI: 86%-89%, p<.001) over a 12-month period, and is associated with 4.77 times greater odds of having any PTLDS-related diagnosis, as compared to controls (95% CI: 4.67-4.87, p<.001). Among those with Lyme disease, having one or more PTLDS-related diagnosis is associated with $3,798 higher total health care costs (95% CI: 3,542-4,055, p<.001) and 66% more outpatient visits (95% CI: 64%-69%, p<.001) over a 12-month period, relative to those with no PTLDS-related diagnoses.

Conclusions: Lyme disease is associated with increased costs above what would be expected for an easy to treat infection. The presence of PTLDS-related diagnoses after treatment is associated with significant health care costs and utilization.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: John Aucott is a board member of the Lyme Disease Research Foundation, which provided a grant to complete this research. The Lyme Disease Research Foundation was not involved in the design and conduct of the study, the statistical analysis or in any publication decisions. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Lyme disease case selection flow diagram.

References

    1. Stanek G, Wormser GP, Gray J, Strle F (2012) Lyme borreliosis. Lancet 379(9814): 461–73. 10.1016/S0140-6736(11)60103-7 - DOI - PubMed
    1. Bacon RM, Kugeler KJ, Mead PS (2008) Surveillance for Lyme disease—United States, 1992–2006. MMWR 57:1–9. - PubMed
    1. Centers for Disease Control and Prevention (2012) Reported Cases of Lyme Disease by Year, United States, 1996–2010. Available: http://www.cdc.gov/lyme/stats/chartstables/casesbyyear.html. Accessed 2013 July 16.
    1. Hinckley AF, Connally NP, Meek JI, Johnson BJ, Kemperman MM, et al. (2014) Lyme Disease Testing by Large Commercial Laboratories in the United States. Clin Infect Dis 59(5): 676–681. 10.1093/cid/ciu397 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention (2013) Notice to Readers: Final 2012 Reports of Nationally Notifiable Infectious Diseases. MMWR 62:669–82. - PMC - PubMed

Publication types